'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.

Scott, Ashleigh;Weber, Nicholas;Tiley, Campbell;Taylor, Kerry;Taper, John;Harrison, Simon;Chan, Kah-Lok;Stark, Richard;Lee, Cindy;Morris, Kirk;Ho, P Joy;Dodds, Anthony;Ramanathan, Sundra;Ramakrishna, Raj;Watson, Anne-Marie;Auguston, Bradley;Kwok, Fiona;Quach, Hang;Warburton, Pauline;Rowlings, Philip;Mollee, Peter;
Leukemia & lymphoma 2018 Vol. 59 pp. 1514-1516
257
scott2018realworldleukemia

Keywords

microarray plasma cell disorders chromoanasynthesis chromothripisis myeloma

Access

DOI:
10.1080/10428194.2017.1387911

Citation

ID: 79006
Ref Key: scott2018realworldleukemia
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
79006
Unique Identifier:
10.1080/10428194.2017.1387911
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
4/5
Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store